Avanos Medical Inc (AVNS)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$11.00

Buy

$12.08

arrow-up$0.05 (+0.43%)

Prices updated at 17 Dec 2025, 23:28 EST
| Prices minimum 15 mins delay
|
Prices in USD

Halyard Health Inc is a medical technology company which provides healthcare supplies and solutions that target the prevention of healthcare associated infections. Its business segments include Surgical and Infection Prevention and Medical Devices.

Income statement

20232024
673m688m
380m381m
4m41m
0.625.89
-62m-392m
53m-346m
Sales, General and administrative335m319m
Interest expenses15m12m
Provision for income taxes2m-17m
Operating expenses376m341m
Income before taxes-8m-403m
Net income available to common shareholders-62m-392m
-1.32-8.53
Net interest income-12m-7m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-1.32-8.53
Free cash flow per share0.78370.7879
Book value/share26.467126.7543
Debt equity ratio0.1518240.180929

Balance sheet

20232024
Current assets487m393m
Current liabilities235m166m
Total capital1,396m954m
Total debt209m170m
Total equity1,236m829m
Total non current liabilities--
Loans159m125m
Total assets1,692m1,154m
Total liabilities--
Cash and cash equivalents88m108m
Common stock46m46m

Cash flow

20232024
Cash at beginning of period128m88m
Cash dividends paid--
15m83m
Investments (gains) losses22m-27m
88m108m
Net income--
32m101m
-18m-18m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.